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ABSTRACT
Many studies using reporter assays have demon-
strated that 3′ untranslated regions (3′-UTRs) regu-
late gene expression by controlling mRNA stability
and translation. Due to intrinsic limitations of het-
erologous reporter assays, we sought to develop a
gene editing approach to investigate the regulatory
activity of 3′-UTRs in their native context. We initially
used dual-CRISPR (clustered, regularly interspaced,
short palindromic repeats)-Cas9 targeting to delete
DNA regions corresponding to nine chemokine 3′-
UTRs that destabilized mRNA in a reporter assay. Tar-
geting six chemokine 3′-UTRs increased chemokine
mRNA levels as expected. However, targeting CXCL1,
CXCL6 and CXCL8 3′-UTRs unexpectedly led to sub-
stantial mRNA decreases. Metabolic labeling assays
showed that targeting these three 3′-UTRs increased
mRNA stability, as predicted by the reporter as-
say, while also markedly decreasing transcription,
demonstrating an unexpected role for 3′-UTR se-
quences in transcriptional regulation. We further
show that CRISPR–Cas9 targeting of specific 3′-
UTR elements can be used for modulating gene ex-
pression and for highly parallel localization of ac-
tive 3′-UTR elements in the native context. Our work
demonstrates the duality and complexity of 3′-UTR
sequences in regulation of gene expression and pro-
vides a useful approach for modulating gene expres-
sion and for functional annotation of 3′-UTRs in the
native context.
INTRODUCTION
3′ untranslated regions (3′-UTRs) have extensive effects
on gene expression during development (1), aging (2), in-
flammation (3) and in diseases including cancer (4). These
processes are precisely controlled by many types of cis-
regulatory elements such as AU-rich elements (AREs) (5),
Pumilio motifs (5), constitutive decay elements (6) and mi-
croRNA targeting sites (7), which modulate mRNA sta-
bility and/or translation through binding to RNA bind-
ing proteins or microRNAs (8). For example, AREs, which
consist of one or more of UAUUUAU repeats, can ei-
ther increase or decrease gene expression. For instance,
the ARE binding protein TTP can regulate tumor growth
through interactingwith the 3′-UTRs of tumor necrosis fac-
tor (TNF-α), cyclooxygenase 2 (COX-2) and vascular en-
dothelial growth factor (VEGF) (4,9). MicroRNAs are con-
served small RNAs that regulate protein translation and
mRNA decay by binding to the 3′-UTRs of target mR-
NAs and thereby inhibit gene expression. It is estimated
thatmore than 60% of the human protein-coding genes har-
bor miRNA target sites in their 3′-UTRs (1). The inter-
play between microRNAs and 3′-UTRs affects almost all
known biological processes, including cell growth, prolifer-
ation and differentiation, as well as development and dis-
ease (1,10).
Evaluation of 3′-UTR activity typically relies upon the
use of heterologous reporter systems in which 3′-UTRs are
placed downstream of the stop codon of a reporter trans-
gene (11,12). Reporter assays are convenient and can be
used for massively parallel analyses of large sets of 3′-UTR
sequences (11,12). However, since reporters cannot detect
3′-UTR effects in their native context, these assays fail
to account for potential interactions between the 3′-UTR
and other sequences, including 5′-UTRs, protein-coding re-
gions and introns. We therefore sought to develop an ap-
proach that could be used to evaluate the effects of 3′-
UTRs on gene expression in the native context. Cas9, an
RNA-directed DNA endonuclease, is a powerful tool that
enables CRISPR (clustered, regularly interspaced, short
palindromic repeats)-guided genome manipulation (13,14).
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In this work, we have used CRISPR/Cas9 to target ge-
nomic DNA transcribed into 3′-UTRs (which we refer to
as ‘3′-UTR DNAs’), which allowed us to observe the ef-
fects of loss of 3′-UTRs in the genomic context and com-
pare these effects with the effects seen in reporter assays. A
4sU (4-thiouridine, a uridine analog) metabolic labeling as-
say was used to monitor the effects of targeting 3′-UTRs
on dynamics of transcripts in the native context. We found
that targeting certain 3′-UTRs can affect both gene tran-
scription andmRNAdecay. Furthermore, we demonstrated
that CRISPR–Cas9 targeting of 3′-UTR cis-elements could
be used to modulate gene expression. We also developed a
highly parallel approach based on a guide RNA (gRNA) li-
brary for localizing specific 3′-UTR elements in their native
context.
MATERIALS AND METHODS
3′-UTR reporter construction
The 3′-UTR reporter BTV has been described previously
(11). BTV contains an LNGFR reference gene and a green
fluorescent protein (GFP) reporter gene, both driven by
a bi-directional tetracycline-regulated promoter. 3′-UTR
sequences were amplified from human genomic DNA
(G304A, Promega) using a forward primer containing an
MluI site and a reverse primer containing a PacI site. Both
the 3′-UTR polymerase chain reaction (PCR) product and
BTV were digested with MluI and PacI and the products
were ligated together. Reporter lentiviruses were produced
as described previously (11).
3′-UTR reporter assays
BEAS-2B human bronchial epithelial cells stably trans-
duced with a tetracycline transactivator transgene
(Beas2B.tTA cells) were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM) (high glucose) with 10%
fetal bovine serum (FBS), glutamine and nonessential
amino acid at 37◦C, 5% CO2 and 100% humidity. For
transduction, conditioned medium containing lentivirus
and fresh medium (1:3) with polybrene (final concentration
8 g/ml) was added to the cells. The medium was replaced
with fresh medium 24 h after adding virus and cultured for
at least 2 weeks. For analysis of steady state reporter (GFP)
mRNA level, the cells were harvested by adding Buffer
RLT (Qiagen) followed by isolation of RNA and genomic
DNA. RNA was reverse transcribed into complementary
DNA (cDNA) using the SuperScript® III First-Strand
Synthesis System (Invitrogen). The Power SYBR Green
PCR Master Mix (Thermo, 4367659) was used for quanti-
tative real-time PCR (qRT-PCR). GFP mRNA levels were
normalized using LNGFR as a housekeeping gene. Effects
of chemokine 3′-UTRs on steady state mRNA levels
were calculated as (normalized GFP mRNA for reporter
with chemokine 3′-UTR)/(normalized GFP mRNA for
empty reporter). To analyze mRNA decay, Beas2B.tTA
cells were treated with doxycycline (Dox) (1 g/ml) and
harvested after 0 and 4 h (t0 and t4) by adding Buffer RLT
(Qiagen). Total RNA was extracted using the RNeasy
mini kit (Qiagen) and reverse transcribed into cDNA using
an oligo-dT primer. GFP mRNA levels were quantified
with qRT-PCR and normalized to the house keeping gene
GAPDH. The remaining mRNA after 4 h was normalized
to the t0 mRNA (t4/t0) and was used to determine mRNA
stability.
pLX-dual-gRNA and pCW-Csy4-hygromycin plasmid con-
struction
The pLX-dual-gRNA and pCW-Csy4-hygromycin lentivi-
ral plasmids were produced for expression of pairs of gR-
NAs. PCRprimer and other oligonucleotide sequences used
in this work are shown in Supplementary Data. PCR was
performed using Phusion High-Fidelity PCR master mix
with HF buffer (NEB, M0531S) at 98◦C for 30 s; followed
by 28 cycles of 98◦C for 30 s, 65◦C for 30 s and 72◦C for
30 s; followed by a final incubation at 72◦C for 5 min. Lig-
ations were performed using T4 DNA ligase (NEB). Mix
& Go Competent Cells––Strain Zymo 5 (Zymo Research,
T3007) were used for all transformations in this work and
all plasmids were verified by sequencing.
The pLX-dual-gRNA lentiviral vector was used to drive
expression of a single transcript containing two gRNAs sep-
arated by a Csy4 cleavage site. pLX-dual-gRNA was de-
rived from pLX-sgRNA-AAVS1 (Addgene #50662) (15)
and pSQ1313 (Addgene #53370) (16). Two fragments of
pSQT1313 were amplified using the primer pair pLX-NdeI-
F1 and pLX-R (PCR1), and the primer pair pLX-F2 and
pLX-NheI-R2 (PCR2). Equal volumes of PCR1 and PCR2
products were used as templates for a second-round PCR
with the primers pLX-NdeI-F1 and pLX-NheI-R2 to pro-
duce the product PCR3. PCR3 and pLX-sgRNA-AAVS1
were each digested with NdeI and NheI and the digestion
products were ligated to produce pLX-dual-gRNA. To in-
sert pairs of gRNAs (gRNA 1 and gRNA 2) into this con-
struct, we performed a single 60 l PCR with five oligonu-
cleotides (3 l of each): Mid 90 (0.1 M), sgRNA 1 (0.1
M), sgRNA 2 (0.1M), attachment1 (10M)and attach-
ment2 (10 M). The PCR product and pLX-dual-gRNA
were digested with BspMI prior to ligation to produce the
final dual gRNA constructs.
The pCW-Csy4-Hygromycin lentiviral vector was pro-
duced as a means to express the ribonuclease Csy4, which
was used to cleave Csy4 sites in pLX-dual-gRNA tran-
scripts and produce a pair of gRNAs. To make pCW-Csy4-
Hygromycin, a fragment of pGL4.11 (Addgene #59744)
was amplified using primers Hyg-F and Hyg-XbaI-R
(PCR4) and a fragment of pCW-Cas9 (Addgene #50661)2
was amplified using primers hPGK-SpeI-F and hPGK-R
(PCR5). Equal volumes of PCR4 and PCR5 were used as
templates for a second-round PCRwith the primers hPGK-
SpeI-F and Hyg-XbaI-R (PCR6). PCR6 and pCW-Cas9
were digested with SpeI and XbaI and ligated to produce
pCW-Csy4-Cas9. To add a hygromycin resistance gene, we
replaced Cas9 with hygromycin as follows. The hygromycin
gene from pSQT834 (Addgene# 53371) (16) was ampli-
fied using the primers Csy4-Nhe-F and Csy4-BamHI-R
(PCR7). The PCR7 product and pCW-Cas9-hygromycin
were digested first with NheI and then with BamHI and
the products were ligated together to generate pCW-Csy4-
Hygromycin.
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CRISPR targeting of 3′-UTRs
To efficiently excise, the majority of each 3′-UTR sequence,
we used a construct expressing a precursor RNA that was
processed by Csy4 to deliver two gRNAs. One gRNA tar-
geted a sequence in the region following the stop codon and
the other targeted a sequence in the region preceding the
polyA signal sequence. In cases where the canonical polyA
signal sequence AAUAAA was not present between 10 and
35 nt upstream of the polyA site, we used PolyAPred (17) to
identify the polyA signal. To avoid deleting any portion of
the coding sequence or stop codon, proximal gRNAs were
based on the antisense strand with the NGG protospacer
adjacent motif (PAM) located within the proximal 3′-UTR.
To avoid deleting the polyA signal sequence, distal gRNAs
were based on the sense strand with the NGG PAM located
upstream of the polyA signal. Positions of each of these
paired gRNAs relative to stop codons and polyA sites are
shown in Supplementary Data. For dual CRISPR target-
ing experiments, BEAS-2B.tTA cells were transduced with
pLX-dual-gRNA (which contains a blasticidin resistance
gene), pCW-Csy4-hygromycin and LentiCRISPRv2 (which
contains a Cas9 gene and a puromycin-resistance gene, Ad-
dgene #52961) (18). Triply transduced cells were selected in
medium containing blasticidin, hygromycin and puromycin
for at least 3 weeks prior to DNA and RNA extraction
(All Prep DNA/RNA mini kit, Qiagen). All studies were
performed using polyclonal populations; sample sizes refer
to the number of technical replicates performed with each
polyclonal population. To detect the 3′-UTR deletions, the
DNA was PCR amplified with a pair of primers flanking
the two sgRNA target sites and analyzed by agarose gel
electrophoresis. Chemokine mRNA levels were measured
by qRT-PCR and normalized using GAPDH mRNA.
Measurement of mRNA decay and transcription using 4sU
metabolic labeling
Beas2B.tTA cells were plated in 15 cm dishes with 30 ml
medium 1 day before labeling and were ∼80% confluent
when 4sU was added. To prepare a 40 mM 4sU stock so-
lution, 100 mg of 4sU (Sigma, T4509) was dissolved in 9.6
ml phosphate buffered saline (PBS) and used immediately.
To monitor mRNA decay (19), 300 l of 4sU stock solu-
tion was added to each plate and mixed into the medium by
gentle shaking followed by a 4 h incubation. After washing
cells twice with 25 ml PBS (pre-warmed to 37◦C), cells were
harvested immediately (t0) or maintained in an incubator
for 4 h (t4). To measure newly synthesized transcripts, 375
l of 4sU stock solution was added to each plate; after a 20
min incubation cells were washed with 20 ml ice-cold PBS
and then harvested in Buffer RLT for total RNA extraction
with the RNeasy mini kit.
The 4sU labeled RNAs in the total RNA isolates were
biotinylated with the following procedure. A 50 mg EZ-
Link Biotin-HPDP (Pierce, 21341) was dissolved in 50 ml
of dimethylformamide (DMF) to produce 1 mg/ml biotin
stock solution. The labeling reaction was carried out in sil-
iconized 15 ml tubes containing 300 l 10× TE buffer (100
mM Tris pH7.4 + 10 mM ethylenediaminetetraacetic acid
(EDTA)), 600 l biotin stock solution, 300–400 g total
RNA and water to 3 ml. The tubes were kept in the dark
and rotated for 2 h. To remove free chemicals, an equal vol-
ume (3 ml) of chloroform/isoamylalcohol (24:1) was added
to the reaction and hand shaken vigorously to homogenize
the mixture. After transfer to MaXtract high density tubes
(Qiagen), hand shaking to produce a homogenous suspen-
sion, waiting for 2–3 min and then spinning at 1500 g for
6 min at 4◦C, the upper aqueous phase was transferred to
multiple 1.7 ml tubes. After addition of 1/10 volume of 5M
NaCl and one volume of isopropanol, tubes were inverted
to mix thoroughly and incubated at room temperature for
10 min and at −20◦C for 20 min. After spinning at 20 000
× g for 30 min at 4◦C, removing the supernatant, adding
one volume of 75% ethanol and spinning at 20 000 × g for
15 min at 4◦C, the supernatant was removed and briefly air-
dried. Pellets were re-dissolved in 50l water, combined and
stored at −80◦C.
Biotin labeled 4sU RNA was isolated with the follow-
ing procedure. A total of 300 g total RNA contain-
ing biotinlylated RNAs was mixed with 10× TE buffer
and water to produce a final RNA concentration of ∼100
g/l, followed by heating at 65◦C for 10 min and im-
mediately placing tubes on ice for 5 min. Next, we used
MACS streptavidin beads and columns (Miltenyi, 130–
074-101) to isolate 4sU RNAs according to the manufac-
turer’s instructions. Final 4sU RNA elutes were purified
with RNeasy MinElute Spin columns (Qiagen, 74204) in
RNase free water. The resulting RNAs were reverse tran-
scribed into cDNAwith oligo-dT primer and used for qRT-
PCR. GAPDH mRNA was used for normalization. We
quantified chemokine mRNA stability by determining the
relative fraction of RNA remaining after 4 h: ([chemokine
RNA at 4 h]/[GAPDH at 4 h])/([chemokine RNA at 0
h]/[GAPDH at 0 h]). We quantified newly synthesized
chemokine mRNA as the ratio of ([chemokine RNA after
20 min pulse]/[GAPDH RNA after 20 min pulse])/([mean
wild-type chemokine RNA after 20 min pulse]/[mean wild-
type GAPDH RNA after 20 min pulse]).
Enhancer–reporter assay
The enhancer–reporter (pLS-mp) contains an enhanced
green fluorescent protein (EGFP) transgene, aminimal pro-
moter and cloning sites for insertion of candidate enhancer
sequences (20). To clone 3′-UTRDNA sequences into pLS-
mP, sequences were amplified with gene specific primers
containing XbaI and SbfI sites. The PCR product and the
plasmid were each digested with XbaI and SbfI and lig-
ated together to produce reporter plasmids. These plas-
mids were packaged in lentivirus and used to transduce
Beas2B.tTA cells. To analyze reporter expression, genomic
DNA and total RNA were extracted from the transduced
cells, followed by reverse transcription of RNA into cDNA
and analysis with qRT-PCR. GFP mRNA and DNA levels
were normalized using GAPDH as a reference gene and en-
hancer activity was calculated as (normalized GFP mRNA
level)/(normalized GFP DNA level).
Highly parallel analysis of 3′-UTR deletions
For a pilot analysis, we designed a small set of gRNAs tar-
geting six sites in and around the N1N2 element in the 3′-
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UTRofCXCL3mRNA.Oligonucleotides containing these
single gRNA sequences (Supplementary Data) were cloned
into the plasmid MP283 mCD4 Cas9, which was modi-
fied from pSicoR by transferring Cas9 expression cassette
and sgRNA cloning sites into it. Equal amounts of the six
plasmids were used to transfect Beas2B.tTA cells in 10-cm
dishes (∼80% confluent). After selection with puromycin
and 2 weeks in culture, cells were harvested for DNA and
total RNA extraction. Total RNA was reverse transcribed
into cDNA and genomic DNA and cDNA was amplified
by PCR using primers flanking the target sites (Supplemen-
tary Data). PCR was performed by incubating at 98◦C for
45 s; followed by 15 cycles of 98◦C for 15 s, 60◦C for 30 s
and 72◦C for 60 s, and a final incubation at 72◦C for 60 s,
using Kapa HiFi polymerase (Kapa Biosystem, KK2611).
The first-round PCR product was used for a second-round
PCR with the primer pair D2nd-F and D2nd-R (Supple-
mentary Data) (98◦C for 45 s; followed by 18 cycles of 98◦C
for 15 s, 60◦C for 30 s and 72◦C for 60; and 72◦C for 60
s; Kapa HiFi polymerase). The PCR product was gel pu-
rified and pooled for sequencing on Illumina Hiseq 2500.
We identified the nine most abundant deletions of each of
three types: (i) deletions within the CXCL3 N1N2 element
( N1N2); (ii) deletions that excised the entire N1N2 ele-
ment and some flanking sequence (N1N2+) and (iii) con-
trol deletions that did not involve the N1N2 element ( C).
For each deletion, we determined the ratio of read counts
from the RNA sample to read counts for the DNA sample
and normalized this to the ratio of CXCL3 3′-UTR read
counts without deletions. Ratios for the  N1N2 and 
N1N2+ deletions were compared with  C deletions using
the Mann–Whitney U-test.
For testing a complete set of oligonucleotides targeting
theCXCL1 3′-UTR, a pool of oligonucleotides correspond-
ing to all possible gRNA recognition sites (Supplementary
Data) was synthesized by Custom Array. The pool was am-
plified by PCR using the forward primer IVT.lib CXCL1
and the reverse primer IVT.lib R (Supplementary Data).
The PCR product was gel purified and used as the tem-
plate for in vitro transcription of sgRNAs (MEGAshort-
script Kit, Thermo, AM1354). The sgRNA transcripts
were purified with MEGAclear Kit (Thermo, AM1908).
A total of 100 ng total of the sgRNA pool was mixed
with 500 ng Cas9 protein (PNA Bio, CP01) and used to
transfect 50 000 Beas2B.tTA cells in a 24-well plate well
with Lipofectamine RNAiMAX (Thermo, 13778030). The
medium was changed 16 h post-transfection. The trans-
fected cells were propagated and passaged for 2 weeks; by
the time of harvesting the cells for DNA and RNA extrac-
tion, the cells were ∼70–80% confluent in a 15-cm dish.
All of the isolated RNA was used to prepare cDNA. To
make the RNA and DNA sequencing libraries, all of the
cDNA and genomic DNA was amplified by PCR with
primers CXCL1.P1 F20 and CXCL1.P3.R30 (Supplemen-
tary Data). The PCR was performed with TaKaRa Ex Taq
polymerase (Clontech, RR001A) and limited to 15 cycles.
The unpurified PCR product was used as template for a sec-
ond round of PCR with Kapa HiFi PCRmaster mix (Kapa
Biosystem, KK2611) and the primers CXCL1full Nx F
and CXCL1full Nx R (Supplementary Data). PCR prod-
ucts were gel purified and used as templates to prepare the
sequencing libraries using the Nextera XT kit (Illumina,
15052164). The libraries were then sequenced using an Il-
lumina HiSeq 2500 (150 nt paired end reads, ∼80 M DNA
reads and 45 M cDNA reads).
Analysis of the high-throughput CRISPR assay data
Reads were aligned to the reference sequence using STAR
aligner (21), with default settings in genome generate mode
and genome SA index N bases = 4. For mapping mode
we used end-to-end read alignment, maximum of 20 mis-
matches, minimum of 40 matched bases and disallowed
multiple alignments. FastQC was used to check read qual-
ity. Samtools sort was used to sort by read name for paired-
end reads. Aftermapping, wewrote custom scripts to ignore
the following: any reads with a deletion<8 nt from the start
or end of the read, since uncertainty in that region can be
high; any deletions of length 1 or 2 bases, since past experi-
ence has shown that these are often likely to be sequencing
errors; any reads with multiple deletions; and any deletions
30 nt or longer. Unmapped regions of the 3′-UTR were as-
sumed to have no deletions. If no deletions were detected,
the read corresponded to the reference sequence.
We grouped any number of reads of DNAmolecules with
the same deletion to be considered a single ‘distinct dele-
tion’. After sorting counts into distinct deletions, we fur-
ther eliminated from our analysis any distinct deletion with
≤6.5 reads/107 reads (8 total reads of RNA or 16 total
reads of DNA). We calculated the count ratio: r = (RNA
counts)/(DNA counts).
For each position along with the 3′-UTR, we identified
the set of deletions that involved that position and calcu-
lated the median value, and 95% confidence interval for
r by following a standard bootstrap algorithm. To esti-
mate P-values for each position, we used a standardMann–
Whitney U-test to compare the distribution of r at a given
location to the distribution of r obtained from all other dis-
tinct deletions. The total r for all distinct deletions was 0.47,
which was similar to the reference sequence ratio of 0.51.
Positions with fewer than four distinct deletions were not
included in the analysis.
Data analysis and statistics
Data are displayed as mean ± s.d., with sample size indi-
cated in figure legends. No randomization or blinding was
performed. Sample size estimation was performed for the
starting number of cells in the high-throughput experiment
by considering both read depth and indel coverage; any se-
quences with deletions <3 or >29 nts were excluded from
analysis. Statistical analysis was performed using two-sided
Student’s t-test, one-way ANOVA and Dunnett’s test, or
Mann–Whitney U-test as indicated in the legends.
Illumina sequencing data
The high-throughput sequencing data are stored at SRA
(SRP100490, https://www.ncbi.nlm.nih.gov/Traces/study/
?acc=SRP100490).
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RESULTS
3′-UTRs from nine chemokines inhibited reporter gene ex-
pression
Chemokines are a family of chemotactic cytokines which
play crucial roles in cell migration and are important in im-
mune responses, the nervous system and cancer (22). Pre-
vious reporter assays have indicated that 3′-UTRs of many
chemokines, including CXCL1, CXCL3 and CXCL8 (IL-8)
(11), are highly active in post-transcriptional gene regula-
tion.We cloned 3′-UTRs from nine human chemokine mR-
NAs into a 3′-UTR reporter (BTV) (Figure 1A). We used
qRT-PCR tomeasure the effects of these 3′-UTRs on steady
state level of the GFP reporter mRNA. Compared with the
control (BTV empty, no 3′-UTR test sequence), each of the
nine 3′-UTRs decreased the mRNA level in Beas2B airway
epithelial cells (Figure 1B), indicating that all had an in-
hibitory effect on gene expression in the reporter context.
Other chemokine 3′-UTRs of similar lengths had minimal
effects on reporter expression (Supplementary Figure S1),
indicating that the 3′-UTR effects were sequence specific.
Disparity of 3′-UTR effects in the reporter context versus the
native context
To evaluate the effects of these chemokine 3′-UTRs in their
native context, we developed a reporter-free approach based
on a dual-CRISPR system (Figure 1C) that was modified
from a previously reported system (16). This system ex-
presses two CRISPR gRNAs that simultaneously target
the proximal 3′-UTR (after the stop codon) and distal 3′-
UTR. To avoid deleting polyA signal sequences and adja-
cent sequences, distal gRNAs were designed to recognize
sequences upstream of the polyA signal of each 3′-UTR
(see ‘Materials and Methods’ section). Analysis of PCR
products from amplification of DNA isolated from poly-
clonal populations of transduced cells showed that the dual-
CRISPR system resulted in loss of targeted 3′-UTR DNA
in a large proportion of cells (Figure 1D). Larger PCR
products were also present and represented either untar-
geted 3′-UTR DNA or 3′-UTR DNA containing small in-
dels (as confirmed using the Surveyor nuclease assay, data
not shown). We then used qRT-PCR to detect the steady
state mRNA level and found that targeting the chemokine
3′-UTRs had significant effects on expression of each gene
(Figure 1E). For six 3′-UTRs, expression was increased as
expected based upon the reporter assays. However, target-
ing of CXCL1, CXCL6 and CXCL8 3′-UTRs unexpectedly
decreased expression. Decreased expression was also seen
with independent pairs of gRNAs targeting slightly smaller
portions of these 3′-UTR DNAs (Supplementary Figure
S2). These results demonstrate that these three 3′-UTR se-
quences had opposite effects on gene expression in the re-
porter context and the native context. Since deletion of 3′-
UTR DNAs was not 100% efficient, our results may un-
derestimate the magnitude of the effect of deleting 3′-UTR
DNAs.
Targeting CXCL1, CXCL6 and CXCL8 3′-UTRs decreased
gene transcription
We next investigated why targeting CXCL1, CXCL6 and
CXCL8 3′-UTRs unexpectedly decreased gene expression.
Since 3′-UTRs typically regulate gene expression post-
transcriptionally (8), we first analyzed the effects of these
3′-UTRs on mRNA stability. In the context of the BTV
reporter, we monitored the effects of these 3′-UTRs on
mRNA decay rate by measuring the mRNA remaining 4
h after adding Dox to terminate gene transcription. Re-
sults showed that each of the three 3′-UTRs destabilized
mRNA (Figure 2A). Tomeasure the effect of these 3′-UTRs
on mRNA stability in the native context, we performed
a 4sU pulse-chase assay (19) to detect mRNA decay in
both untreated and 3′-UTR-targeted Beas2B cells. Target-
ing these three 3′-UTRs increased mRNA stability, indicat-
ing that these 3′-UTRs also destabilize mRNA in their na-
tive contexts (Figure 2B). We therefore concluded that ef-
fects on mRNA stability could not explain why targeting
CXCL1, CXCL6 and CXCL8 3′-UTRs decreased gene ex-
pression. We next examined the effects of targeting these
3′-UTRs on gene transcription. We measured newly syn-
thesized chemokine transcripts during a 20 min pulse with
4sU (19). Targeting each of these 3′-UTRs substantially de-
creased levels of newly synthesized chemokine transcripts
(Figure 2C and D), indicating reduced gene transcription.
Taken together, we demonstrated that targeting CXCL1,
CXCL6 and CXCL8 3′-UTRs had dual and opposing ef-
fects on transcription and post-transcriptional regulation.
The post-transcriptional effect was overcome by the tran-
scriptional effect.
CXCL1, CXCL6 and CXCL8 3′-UTR DNAs lacked canoni-
cal enhancer activity
To seek further insights, we tested these three 3′-UTR
DNAs in a GFP-based enhancer reporter (Figure 3A) (20).
Enhancers are generally considered to be orientation in-
dependent (23), but orientation-dependent enhancers have
been reported (24) so we tested these 3′-UTRs DNAs in
both orientations (5′→3′, Fw; 3′→5′, Rv). We transduced
Beas2B cells with these reporter viruses and measured re-
porter mRNA. The expression of GFPmRNA in the whole
population of cells was not increased by any of the 3′-
UTR DNAs in either orientation (Figure 3B). In contrast,
the positive control SV40 enhancer increased mRNA level
300-fold (Figure 3B). We therefore conclude that CXCL1,
CXCL6 and CXCL8 3′-UTR DNA sequences lack canoni-
cal enhancer activity.
Modulating gene expression by targeting CRISPR–Cas9 to
3′-UTR cis-elements
Modulating gene expression is critical for understanding
biological pathways and could be used therapeutically. 3′-
UTRs are a set of readily localized regions that provide
a large reservoir of cis-regulatory elements that serve as
binding sites for RNA binding proteins or microRNAs that
decrease or increase mRNA stability and/or translation
(7,25). Targeting 3′-UTRs may therefore provide an effi-
cient alternative formodulating gene expression. To test this
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concept, we used six gRNAs to target a known inhibitory
element (N1N2) in the CXCL3 3′-UTR (11) and its sur-
rounding regions (Figure 4A). This caused short deletions
within or distant from N1N2 (likely directed by single gR-
NAs) and longer deletions (likely directed by a pair of gR-
NAs) that excised N1N2 and some surrounding sequence
from the genome (Figure 4B). As expected, deletions within
N1N2 and longer deletions that removed N1N2 increased
CXCL3 mRNA levels whereas control deletions did not
(Figure 4C). This demonstrates that targeting individual 3′-
UTR elements can be an alternative approach for modulat-
ing gene expression.
A highly parallel approach for localizing active 3′-UTR ele-
ments in their native context
3′-UTRs modulate gene expression via cis-elements, but ex-
perimentally predicting and cataloging these elements re-
mains challenging. Reporter assays can be used to local-
ize cis-elements in heterologous contexts but they may not
reflect the influence of the native context, so we sought to
develop a high-throughput method for localizing 3′-UTR
elements in their native context. The CXCL3 N1N2 tar-
geting experiment demonstrated that the combination of
CRISPR/Cas9-guided in situmutations withmassively par-
allel sequencing can be used to map active elements in 3′-
UTRs. This inspired us to create a large set of deletions in 3′-
UTRs using all possible CRISPR gRNAs that recognize the
3′-UTR DNA. The effects of targeting were determined by
measuring mRNA levels using massively parallel sequenc-
ing. We applied this strategy to localize regulatory elements
in the CXCL1 3′-UTR, which is 781 nt-long. We synthe-
sized aDNAoligonucleotide pool containing all 64 possible
gRNA sequences targeting the CXCL1 3′-UTR. Following
in vitro transcription, the gRNA pool was combined with
Cas9 protein and introduced into BEAS-2B cells by trans-
fection (26), followed by analysis of CXCL1 3′-UTR DNA
and RNA sequences (Figure 5A). This method resulted in a
total of 1176 distinct 3–29 nt-long deletions that were suffi-
ciently frequent for analysis (>6.5 reads/107 reads). These
deletions covered most of the CXCL1 3′-UTR except for
three low GC regions (Figure 5B). Deletions of certain re-
gions, including regions 6–23 and 632–651 led to significant
decreases in expression, whereas deletions of other regions,
including region 562–581, increased expression (Figure 5C
and D). Region 562–581 contains a sequence that is very
similar to theN1N2 active element inCXCL3 and hereafter,
we refer to this as the CXCL1 N1N2 element (Figure 4A).
Validation of active regions identified using the massively par-
allel approach
We selected three active regions (6–23, 562–581 and 632–
651) and an inactive control region (189–208) for valida-
tion with individual gRNAs. As predicted, targeting re-
gions 6–23 and 632–651 decreased CXCL1 expression, tar-
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geting 562–581 (N1N2) increased expression and targeting
the negative control region had no significant effect (Figure
5E). To determine whether effects of targeting these regions
were due to altered transcription or changes in mRNA sta-
bility, we performed 4sU labeling assays after targeting with
individual gRNAs (Figure 5F and G). We found that gR-
NAs that decreased mRNA levels by targeting regions 6–
23 and 632–651 decreased transcription with no significant
effect on mRNA stability. The magnitude of the effects of
targeting these two regions (40 and 45% reduction in tran-
scription, respectively) suggests that these regions explain a
substantial portion of the effects of dual CRISPR targeting
of almost the entire 3′-UTR (82% reduction, Figure 2C). In
contrast, a gRNA that increased the mRNA level by target-
ing the region 562–581 (N1N2) increased mRNA stability
and had no significant effect on transcription. These results
validate the ability of the massively parallel approach to de-
tect active elements and identify elements with distinct ef-
fects on either transcription or mRNA stability.
DISCUSSION
One consequence of evolution is that the human genome
acquired many noncoding sequences that play crucial roles
in controlling development, metabolism, and aging via reg-
ulation of gene expression (18). Variants in noncoding reg-
ulatory sequences are often associated with the risk of dis-
ease (27). It therefore becomes a fundamental goal to com-
pletely understand the functions of noncoding sequences.
Well-characterized noncoding sequences include promot-
ers, enhancers, noncoding RNAs and 5′- and 3′-UTRs of
mRNA. We and others have relied extensively on reporter
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assays to functionally characterize noncoding sequences in-
cluding 3′-UTRs (11), 5′-UTRs (28), promoters (29) and
enhancers (20). Reporter-based methods are efficient but
cannot provide complete insights into the function of reg-
ulatory elements in their native context. Cre-Lox mediated
recombination has been used to study 3′-UTRs in the na-
tive context in mice (30), but this approach is costly and
time consuming and is not well suited for use outside of
mouse models. CRISPR/Cas9-mediated gene editing has
recently become a powerful tool for efficient perturbation of
genomic sequences (13), providing a powerful approach for
investigating the biological effects of noncoding sequences
in the native context. By expressing dual CRISPR gRNAs,
we could delete large portions of 3′-UTRDNAs.Metabolic
labeling with 4sU allowed us to monitor the dynamics of
transcription and mRNA degradation with minimal inter-
ference with normal cell growth. This approach led us to
find disparities between 3′-UTR effects in the artificial ver-
sus the native contexts.
3′-UTRs have well known roles in post-transcriptional
gene regulation (8,31). Reporter assays showed that each of
the nine chemokine 3′-UTRs we studied decreased mRNA
levels and that those effects were due to destabilization of
the reporter mRNA. Based on these results, we expected
that CRISPR targeting of these 3′-UTRs in their native con-
text would increase mRNA levels. This expected result was
seen for six of the nine 3′-UTRs we studied. For the remain-
ing three 3′-UTRs, we used the 4sU pulse-chase approach
to show that, despite the decreases in steady state mRNA
levels, CRISPR targeting still had the expected effect on
mRNA stability. Surprisingly, by directly measuring newly
synthesized transcripts we found that targeting CXCL1,
CXCL6 andCXCL8 3′-UTRs decreased gene transcription.
Promoters and enhancers are usually believed to be the cru-
cial cis-elements that control transcription. Our work sug-
gests that 3′-UTRs or 3′-UTR DNAs can also contribute
to transcriptional regulation. We considered the possibility
that the transcriptional effect of targeting CXCL1, CXCL6
andCXCL8 3′-UTRsmight be due to deletion of enhancers
contained within these 3′-UTR DNAs. Enhancer–reporter
assays showed that these 3′-UTR DNAs did not behave as
canonical enhancers. It is also possible that CRISPR tar-
geting of CXCL1, CXCL6 and CXCL8 3′-UTRs disrupted
genomic structures or epigenetic markers that are essen-
tial for efficient transcription. For example, elements up-
stream of the polyA signal may play roles in regulating
polyadenylation, a process that is linked to transcriptional
termination (32). Although our strategy was designed to
avoid disrupting polyA signal sequences themselves, it is
possible that some effects of CRISPR targeting on tran-
scription may be due to disruption of auxiliary sequences
involved in polyadenylation and CRISPR targeting could
be a useful method for identifying these auxiliary sequences.
Additional work will be required to distinguish these pos-
sibilities. However, our work suggests that 3′-UTRs may
have distinct roles in simultaneously promoting transcrip-
tion and mRNA decay, which might be beneficial for estab-
lishing a new balance in response to rapid environmental
changes. A similar dual role was reported for a promoter se-
quence that promotes both transcription and mRNA decay
(33), suggesting regulatory sequences may play more com-
plicated roles than we have thought.
We also sought to modulate gene expression by target-
ing CRISPR–Cas9 to 3′-UTR cis-regulatory elements. Var-
ious other approaches have been used previously to modu-
late gene expression. Transcription can be modulated using
customized DNA-binding proteins (34) or by combining
gRNAs with nuclease-deactivated forms of Cas9 (dCas9)
to repress expression (CRISPRi) (35) or increase expres-
sion (CRISPRa) (36). Post-transcriptional gene silencing
has been accomplished using small interfering RNAs and
short hairpin RNAs (34). Each of these approaches has
many applications but are limited by the need to continue
to express exogenous proteins or RNAs that may have non-
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specific deleterious effects. Alternatively, durable modula-
tion of gene expression could be accomplished by editing
endogenous regulatory elements that control gene expres-
sion. Targeting of promoters, enhancers and silencers is fea-
sible but challenging since these regions and the regulatory
elements that they contain are often difficult to localize.
3′-UTRs contain hundreds of thousands of predicted cis-
elements recognized by RNA-binding proteins and miR-
NAs (6,25) and many more active elements that have been
identified experimentally (11).We demonstrated that target-
ing CRISPR–Cas9 to a known 3′-UTR cis-regulatory ele-
ment, theCXCL3N1N2 element, increasedCXCL3 expres-
sion 2-fold (Figure 4C). Targeting 3′-UTR elements with in-
dividual gRNAs or gRNA pairs allows for various modu-
lating effects on gene expression and is not limited by the
requirement of optimizing alternative dCas9 fusion pro-
teins for robust activity found with CRISPRa/i (26). Tar-
geting 3′-UTRs by delivery of in vitro transcribed gRNAs
and Cas9 protein avoids the continuous expression of ex-
ogenous proteins, which can be beneficial for animal model
Nucleic Acids Research, 2017, Vol. 45, No. 18 10809
generation and therapeutic applications (37). However, tar-
geting 3′-UTRs can be limited by lack of gRNA targets in
AT-rich regions or by lack of active regulatory elements in
some genes.
We extended the CRISPR-based 3′-UTR targeting
method by using a gRNA library for high-throughput lo-
calization of regulatory elements in full length 3′-UTRs.
Reporter assays in combination with massively parallel se-
quencing have previously been used to systematically local-
ize cis-elements in regulatory sequences (11,33). CRISPR–
Cas9 was recently used for screening of DNA regulatory el-
ements in enhancers and promoters (14,38,39), represent-
ing a promising approach that can be used to dissect non-
coding regulatory sequences in the native contexts. Simi-
larly, CRISPR–Cas9 can be used for high-throughput dis-
section of functional enhancer–promoter connections with
CRISPRi (40) and for pooled screens for identification of
functionally important noncoding regions (41). Libraries
contained paired gRNAs have also been used to allow
for identification of active DNA regulatory elements by
deleting kilobase-long segments of DNA (42). Since en-
hancer and promoter sequences are not transcribed, en-
hancer mutations must be inferred from analysis of lentivi-
ral sequences that are transcribed into gRNAs. In con-
trast, because the 3′-UTR is located within gene transcripts,
functional effects can be directly linked to mutations by
using massively parallel sequencing to simultaneously de-
tect mutations and transcript levels, which allows for high-
throughput localization of active 3′-UTR regulatory ele-
ments in the native contexts. Since there is no requirement
for inferringmutations from gRNA sequences, we were able
to use recombinant Cas9 and in vitro transcribed gRNA
as an alternative for 3′-UTR targeting, which should make
this approach particularly useful in cases cells that are dif-
ficult to transduce with lentivirus. Therefore, our reporter-
free method for targeting 3′-UTRs is suitable for functional
annotation of 3′-UTRs in the native context. We used the
high-throughput approach to identify regions that regulate
mRNA abundance, and then used individual gRNAs and
4sU labeling to determine how targeting these regions af-
fected transcription and mRNA stability. In principle, it
should also be possible to used pooled gRNAs in combina-
tion with 4sU labeling to directly identify regions that reg-
ulate transcription and stability.
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